BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 15718158)

  • 1. Perspectives for cytokine antagonist therapy in COPD.
    de Boer WI
    Drug Discov Today; 2005 Jan; 10(2):93-106. PubMed ID: 15718158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agents against cytokine synthesis or receptors.
    Yamagata T; Ichinose M
    Eur J Pharmacol; 2006 Mar; 533(1-3):289-301. PubMed ID: 16457805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging trends in the therapy of COPD: novel anti-inflammatory agents in clinical development.
    Fitzgerald MF; Fox JC
    Drug Discov Today; 2007 Jun; 12(11-12):479-86. PubMed ID: 17532533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of inhaled HFA beclomethasone on pulmonary function and symptoms in patients with chronic obstructive pulmonary disease.
    John M; Bosse S; Oltmanns U; Schumacher A; Witt C
    Respir Med; 2005 Nov; 99(11):1418-24. PubMed ID: 15894479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacological treatment of COPD and future of anti-inflammatory therapy].
    Watz H; Bitter-Suermann S; Kanniess F; Magnussen H
    Med Klin (Munich); 2006 Apr; 101(4):283-92. PubMed ID: 16607484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New treatments for chronic obstructive pulmonary disease.
    Barnes PJ
    Ann Ist Super Sanita; 2003; 39(4):573-82. PubMed ID: 15098577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roflumilast for the treatment of chronic obstructive pulmonary disease.
    Antoniu SA
    Curr Opin Investig Drugs; 2006 May; 7(5):412-7. PubMed ID: 16729716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-9 as a possible therapeutic target in both asthma and chronic obstructive airways disease.
    McNamara PS; Smyth RL
    Drug News Perspect; 2005 Dec; 18(10):615-21. PubMed ID: 16491163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of chronic obstructive pulmonary disease: moving beyond the asthma algorithm.
    Gordon E; Lazarus SC
    J Allergy Clin Immunol; 2009 Nov; 124(5):873-80; quiz 881-2. PubMed ID: 19895979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New treatments for chronic obstructive pulmonary disease and viable formulation/device options for inhalation therapy.
    Onoue S; Misaka S; Kawabata Y; Yamada S
    Expert Opin Drug Deliv; 2009 Aug; 6(8):793-811. PubMed ID: 19558334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological actions of statins: potential utility in COPD.
    Young RP; Hopkins R; Eaton TE
    Eur Respir Rev; 2009 Dec; 18(114):222-32. PubMed ID: 20956147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New therapies for chronic obstructive pulmonary disease.
    Barnes PJ
    Med Princ Pract; 2010; 19(5):330-8. PubMed ID: 20639653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical course of chronic obstructive pulmonary disease: review of therapeutic interventions.
    Anzueto A
    Am J Med; 2006 Oct; 119(10 Suppl 1):46-53. PubMed ID: 16996899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of cigarette smoke on airway inflammation in asthma and COPD: therapeutic implications.
    Tamimi A; Serdarevic D; Hanania NA
    Respir Med; 2012 Mar; 106(3):319-28. PubMed ID: 22196881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Handle with care: targeting neutrophils in chronic obstructive pulmonary disease and severe asthma?
    Beeh KM; Beier J
    Clin Exp Allergy; 2006 Feb; 36(2):142-57. PubMed ID: 16433851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of the anti-inflammatory properties of small-molecule IkappaB Kinase (IKK)-2 inhibitors by comparison with adenoviral-mediated delivery of dominant-negative IKK1 and IKK2 in human airways smooth muscle.
    Catley MC; Sukkar MB; Chung KF; Jaffee B; Liao SM; Coyle AJ; Haddad el-B; Barnes PJ; Newton R
    Mol Pharmacol; 2006 Aug; 70(2):697-705. PubMed ID: 16687566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging trends in the therapy of COPD: bronchodilators as mono- and combination therapies.
    Fitzgerald MF; Fox JC
    Drug Discov Today; 2007 Jun; 12(11-12):472-8. PubMed ID: 17532532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COPD: is there light at the end of the tunnel?
    Barnes PJ
    Curr Opin Pharmacol; 2004 Jun; 4(3):263-72. PubMed ID: 15140418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biologic and pharmacologic therapies in clinical development for the inflammatory response in COPD.
    Morjaria JB; Malerba M; Polosa R
    Drug Discov Today; 2010 May; 15(9-10):396-405. PubMed ID: 20223295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological treatment in asthma and COPD.
    Hoshino T; Toda R; Aizawa H
    Allergol Int; 2009 Sep; 58(3):341-6. PubMed ID: 19628978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.